
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes

14 hours ago
14 hours ago
touchFOCUS for touchONCOLOGY
In this concise interview, Dr Corey Cutler discusses unmet needs in steroid-refractory chronic GvHD and how they may be addressed with new and emerging therapies.
The expert:
- Dr Corey Cutler - Dana-Farber Cancer Institute, Boston, MA, USA
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from Sanofi US.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com

14 hours ago
14 hours ago
touchFOCUS for touchHAEMATOLOGY
In this concise interview, Dr Corey Cutler discusses unmet needs in steroid-refractory chronic GvHD and how they may be addressed with new and emerging therapies.
The expert:
- Dr Corey Cutler - Dana-Farber Cancer Institute, Boston, MA, USA
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from Sanofi US.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchHAEMATOLOGY.com

Thursday Feb 06, 2025
Updates in BCMA-directed therapies in multiple myeloma from ASH 2024
Thursday Feb 06, 2025
Thursday Feb 06, 2025
touchCONGRESS for ONCOLOGY
Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of the data for clinical practice.
The experts
- Prof. Katja Weisel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Dr Nisha Joseph, Emory University School of Medicine, Atlanta, GA, USA
- Prof. Roman Hájek, University Hospital Ostrava, Ostrava, Czech Republic
This touchPODCAST is for HCPs outside of the USA and UK.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/bcma-directed-therapies-in-multiple-myeloma-ash2024/

Thursday Feb 06, 2025
Updates in BCMA-directed therapies in multiple myeloma from ASH 2024
Thursday Feb 06, 2025
Thursday Feb 06, 2025
touchCONGRESS for touchHAEMATOLOGY
Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of the data for clinical practice.
The experts
- Prof. Katja Weisel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Dr Nisha Joseph, Emory University School of Medicine, Atlanta, GA, USA
- Prof. Roman Hájek, University Hospital Ostrava, Ostrava, Czech Republic
This touchPODCAST is for HCPs outside of the USA and UK.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/bcma-directed-therapies-in-multiple-myeloma-ash2024/

Thursday Jan 30, 2025
RAS mutations and personalized cancer care: Targeting the future
Thursday Jan 30, 2025
Thursday Jan 30, 2025
touchEXPERT OPINIONS for touchONCOLOGY
Listen to a medical oncologist, a pancreatic cancer specialist and a lung cancer specialist discuss the role of RAS mutations in solid tumours, notably pancreatic cancer and NSCLC, and how they may be therapeutically targeted to improve patient outcomes.
The experts
- Dr David S Hong, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Eileen M O’Reilly, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA
- Dr Rebecca S Heist, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
This touchPODCAST is for healthcare professionals outside of the UK.
This activity is funded by an independent medical education grant from Revolution Medicines.
This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/mutations-and-personalized-cancer-care-targeting-the-future/

Wednesday Jan 29, 2025
What’s new in primary ITP? Key updates from ASH 2024
Wednesday Jan 29, 2025
Wednesday Jan 29, 2025
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.
The experts
- Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA
- Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK
- Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana, Slovenia
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#

Wednesday Jan 29, 2025
What’s new in primary ITP? Key updates from ASH 2024
Wednesday Jan 29, 2025
Wednesday Jan 29, 2025
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.
The experts
- Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA
- Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK
- Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana, Slovenia
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#

Friday Jan 24, 2025
Focused insights: Data implications of ADCs in NSCLC treatment
Friday Jan 24, 2025
Friday Jan 24, 2025
touchFOCUS for touchRESPIRATORY
Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these data may impact clinical practice in the future.
The expert
- Prof. Céline Mascaux, Strasbourg University, Strasbourg, France
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca.
This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
www.touchrespiratory.org/ADCs-in-NSCLC

Friday Jan 24, 2025
Focused insights: Data implications of ADCs in NSCLC treatment
Friday Jan 24, 2025
Friday Jan 24, 2025
touchFOCUS for touchONCOLOGY
Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these data may impact clinical practice in the future.
The expert
- Prof. Céline Mascaux, Strasbourg University, Strasbourg, France
This touchPODCAST is for HCPs only
This activity is funded by an independent medical education grant from AstraZeneca.
This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
www.touchoncology.org/ADCs-in-NSCLC

Tuesday Jan 21, 2025
Tuesday Jan 21, 2025
touchSYMPOSIUM for touchHAEMATOLOGY
Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, CA, USA.
Symposium chair Prof. Cindy Neunert is joined by Dr María Eva Mingot Castellano and Prof. David Kuter to discuss the impact of immune thrombocytopenia (ITP) on patients and review current and emerging treatment strategies.
- Session 1: Prof. Cindy Neunert considers how ITP affects patients' lives, including the impact on health-related quality of life
- Session 2: Dr Mingot Castellano discusses two illustrative patient cases and the application of current management strategies
- Session 3: Prof. David Kuter reviews emerging targeted treatment options for ITP, with a focus on their mechanisms of action and the latest data
- Session 4: A panel discussion with all three faculty on shared decision-making and collaboration in the clinic
This touchPODCAST is for HCPs in the USA.
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncologyime.org